Yousef Ajlouni
Overview
Explore the profile of Yousef Ajlouni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
238
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alboraie M, Tanwandee T, Xu X, Nikolova D, Estupinan E, Ghazinyan H, et al.
Ann Hepatol
. 2024 Oct;
29(6):101573.
PMID: 39477629
No abstract available.
2.
Shiha G, Alswat K, Khatry M, Sharara A, Ormeci N, Waked I, et al.
Lancet Gastroenterol Hepatol
. 2020 Nov;
6(1):57-64.
PMID: 33181119
With the increasing prevalence of obesity and type 2 diabetes, fatty liver disease associated with metabolic dysfunction is a global health problem, especially because it is one of the earliest...
3.
Fouad Y, Waked I, Bollipo S, Gomaa A, Ajlouni Y, Attia D
Liver Int
. 2020 Apr;
40(6):1254-1261.
PMID: 32301554
In medicine, language matters and the words used to name and describe a disease can have a profound impact on patients and their families. Over the last two decades, many...
4.
Gasche C, Reinisch W, Huber W, Leshinsky-Silver E, Levine A, Abdul-Baki H, et al.
Inflamm Bowel Dis
. 2010 Sep;
17(6):1438.
PMID: 20842643
No abstract available.
5.
Haines M, Ajlouni Y, Irving P, Sparrow M, Rose R, Gearry R, et al.
Inflamm Bowel Dis
. 2010 Sep;
17(6):1301-7.
PMID: 20812329
Background: Circulating concentrations of 6-thioguanine nucleotide (6-TGN) and 6-methyl mercaptopurine (6-MMP) are associated with thiopurine efficacy and may predict toxicity. This study aimed to examine retrospectively the utility of measuring...
6.
Ajlouni Y, Iser J, Gibson P
J Gastroenterol Hepatol
. 2007 Mar;
22(4):486-90.
PMID: 17376038
Background And Aim: Endoscopic balloon dilatation (EBD), a non-surgical treatment option for intestinal strictures in Crohn's disease, appears to be applied infrequently, possibly due to the perceived risk of perforation...
7.
Gearry R, Ajlouni Y, Nandurkar S, Iser J, Gibson P
Inflamm Bowel Dis
. 2007 Mar;
13(8):1009-15.
PMID: 17352386
Background: The use of 5-aminosalicylate (5-ASA) drugs in Crohn's disease (CD) is controversial, with their continuing apparent widespread use despite high-level evidence indicating marginal benefit at best and international guidelines...